Targeting transforming growth factor-β signaling in liver metastasis of colon cancer

Bixiang Zhang, Sunil K. Halder, Sanguo Zhang, Pran K. Datta

Research output: Contribution to journalArticlepeer-review

121 Scopus citations


Despite a primary tumor suppressor role, there is compelling evidence suggesting that TGF-β can promote tumor growth, invasion and metastasis in advanced stages of colorectal cancer. Blocking these tumor-promoting effects of TGF-β provides a potentially important therapeutic strategy for the treatment of colorectal cancer. However, little is known about how the inhibitors of TGF-β receptor kinases affect colorectal carcinogenesis in vivo. Here, we have observed that a novel dual kinase inhibitor of TGF-β type I and type II receptors, LY2109761, inhibits TGF-β-mediated activation of Smad and non-Smad pathways in CT26 colon adenocarcinoma cells having K-Ras mutation. The inhibitor attenuates the oncogenic effects of TGF-β on cell migration, invasion and tumorigenicity of CT26 cells. Furthermore, LY2109761 decreases liver metastases and prolongs survival in an experimental metastasis model. These findings suggest that the dual kinase inhibitor LY2109761 has potential therapeutic value for metastatic colorectal cancer.

Original languageEnglish (US)
Pages (from-to)114-120
Number of pages7
JournalCancer Letters
Issue number1
StatePublished - May 8 2009
Externally publishedYes


  • Bioluminescence
  • Colon cancer
  • LY2109761
  • Liver metastasis
  • TGF-β

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Targeting transforming growth factor-β signaling in liver metastasis of colon cancer'. Together they form a unique fingerprint.

Cite this